T akotsubo syndrome (TTS), also known as broken heart syndrome, is a severe and acute heart failure syndrome that often resolves spontaneously but can also be associated with significant mortality. TTS predominantly affects postmenopausal women and is usually triggered by identifiable physical or emotional stress. Considerable evidence suggests the precipitating factor to be the catecholamine surge from excess sympathetic activity that occurs during these events because it can be mimicked by exogenous catecholamine administration (1). TTS was first described in 1990 in Japan were too small in number to make any firm conclusions. However, the study does build on several previous reports of inflammatory damage in TTS patients and also feeds into a large body of literature from animal models with similar observations. Evidence over many years suggested the activation of inflammatory components by high catecholamine levels. In TTS patients, endomyocardial biopsies showed mononuclear infiltrate, contraction-band necrosis (5), and myocardial inflammationÀmediated edema (6). In rodent models, the involvement of catecholamines in stress-induced heart injury was first described in 1959 (7). This study showed necrotic myocardial lesions induced by isoproterenol in the rat, and was followed by many subsequent studies SEE PAGE 766 
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In conclusion, it is not inconceivable for TTS to fall into an expanding category of disease, including atherosclerosis and heart failure, that are now being recognized to have a significant auto-inflammatory and/or autoimmune component. We therefore believe that there is great benefit in thorough studies of the acute and long-term immunological effects of TTS.
